Clinuvel Posts Tenth Straight Annual Profit, Cash Reserves Jump 12% to $252M
CUVL sits 27% above its 52-week low of $5.98 on elevated volume (2.9× avg).
Summary
Clinuvel reported FY2026 results: revenue of $94.0M (down 1% YoY), net profit after tax of $33.9M (down 6%), and cash reserves up 12% to $252.1M. The company declared a $0.05 per share dividend, its ninth consecutive annual payout. Management highlighted financial independence and flexibility to self-fund U.S. expansion. The results follow the July restructuring announcement and Nasdaq listing; the investor webinar is scheduled for today at 18:00 AEST.
At the time of this announcement, CUVL was trading at $7.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $382.8M. The 52-week trading range was $5.98 to $9.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.